Griffin Pathology Consultants P.C. Teplitzky & Company PC Revenue, Growth & Competitor Profile

DBA C/O TEPLITZKY & COMPANY, PC
DBA GRIFFIN PATHOLOGY CONSULTANTS, PC
DBA GRIFFIN PATHOLOGY CONSULTANTS, PC C/O NESTOR & CLAYTON LLP
DBA GRIFFIN PATHOLOGY CONSULTANTS, PC C/O TEPLITZKY & CO
DBA TEPLITZKY COMPANY, PC

Company Profile & Annual Report for Griffin Pathology Consultants P.C. Teplitzky & Company PC

Access the complete profile.

Griffin Pathology Consultants P.C. Teplitzky & Company PC Fast Facts

Revenue	Less than $1 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	621511 Medical Laboratories
Address	One Bradley Rd., Bldg 600 Woodbridge, CT 06525

Note: Revenues for privately held companies are statistical evaluations.


Griffin Pathology Consultants P.C. Teplitzky & Company PC's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Griffin Pathology Consultants P.C. Teplitzky & Company PC's annual revenues are Less than $1 million (see exact revenue data)
• What industry is the company in?
  • Griffin Pathology Consultants P.C. Teplitzky & Company PC is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Griffin Pathology Consultants P.C. Teplitzky & Company PC Annual Revenue and Growth Rate

Griffin Pathology Consultants P.C. Teplitzky & Company PC	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	Less than $1 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Griffin Pathology Consultants P.C. Teplitzky & Company PC's revenues are gauged from an analysis of company filings.

Griffin Pathology Consultants P.C. Teplitzky & Company PC's Income Statement (based on Industry Averages)

Griffin Pathology Consultants P.C. Teplitzky & Company PC P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Griffin Pathology Consultants P.C. Teplitzky & Company PC's Largest Competitors

A competitive analysis shows these companies are in the same general field as Griffin Pathology Consultants P.C. Teplitzky & Company PC, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Griffin Pathology Consultants P.C. Teplitzky & Company PC. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PRECIPIO	New Haven, CT	100
ELM FAMILY DENTAL ASSOCIATES	West Haven, CT	39
CONSULTANTS IN PATHOLOGY P.C	Woodbridge, CT	9
AGILIX	New Haven, CT	8
CONNECTICUT SPINE & REHAB	New Haven, CT	7
GRIFFIN PATHOLOGY CONSULTANTS P.C. TEPLITZKY & COMPANY PC	Woodbridge, CT	5

Future Competition: Griffin Pathology Consultants P.C. Teplitzky & Company PC's Fastest Growing Competitors

These companies are in the same general field as Griffin Pathology Consultants P.C. Teplitzky & Company PC and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)